论文部分内容阅读
澳大利亚治疗用品监督管理局(TGA)批准cervarix用于预防人乳头状瘤病毒(HPV)16型和18型引发的宫颈癌和癌前病变(70%的宫颈癌可由HPV16和HPV18引发)。澳大利亚是葛兰素史克(GSK)公司这一产品的第一个重要市场。该疫苗可用于10～45岁的女性,GSK公司称其是第一个被指定用于26岁以?
Cervix is approved by the Australian TGA for the prevention of cervical and precancerous lesions of human papillomavirus types 16 and 18 (70% of cervical cancers are caused by HPV16 and HPV18). Australia is the first major market for this product from GSK. The vaccine can be used for women aged 10 to 45 years, GSK said it was the first designated for the age of 26?